Similar to what we reported for PLAGL1/2-amplified tumors [11], initial diagnoses and tumor localizations varied for patients with PLAG1-fused tumors and included different high- and low-grade tumor entities as well as different infratentorial and supratentorial locations, leading to different treatment regimens. Here, PLAG1 is linked to neoplasm.